tiprankstipranks
Trending News
More News >
Zylox-Tonbridge Medical Technology Co., Ltd. Class H (DE:818)
:818
Germany Market

Zylox-Tonbridge Medical Technology Co., Ltd. Class H (818) Financial Statements

Compare
0 Followers

Zylox-Tonbridge Medical Technology Co., Ltd. Class H Financial Overview

Zylox-Tonbridge Medical Technology Co., Ltd. Class H's market cap is currently €750.00M. The company's EPS TTM is €0.012064284; its P/E ratio is 55.78; Zylox-Tonbridge Medical Technology Co., Ltd. Class H is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 782.48M¥ 527.75M¥ 334.09M¥ 177.91M¥ 27.63M
Gross Profit¥ 559.89M¥ 384.99M¥ 252.67M¥ 131.88M¥ 16.29M
Operating Income¥ 60.91M¥ -156.52M¥ -222.19M¥ -218.06M¥ -97.78M
EBITDA¥ 65.30M¥ -41.60M¥ -86.56M¥ -199.94M¥ -90.16M
Net Income¥ 100.26M¥ -78.73M¥ -120.41M¥ -186.05M¥ -99.48M
Balance Sheet
Cash & Short-Term Investments¥ 1.28B¥ 1.51B¥ 1.86B¥ 2.93B¥ 317.26M
Total Assets¥ 3.45B¥ 3.38B¥ 3.25B¥ 3.25B¥ 503.97M
Total Debt¥ 90.91M¥ 55.88M¥ 14.00M¥ 9.40M¥ 34.22M
Net Debt¥ -327.20M¥ -1.03B¥ -1.19B¥ -1.41B¥ -25.34M
Total Liabilities¥ 351.56M¥ 328.32M¥ 159.54M¥ 103.61M¥ 79.28M
Stockholders' Equity¥ 3.10B¥ 3.05B¥ 3.09B¥ 3.14B¥ 424.69M
Cash Flow
Free Cash Flow¥ 0.00¥ -92.48M¥ -236.60M¥ -205.80M¥ -127.47M
Operating Cash Flow¥ 0.00¥ 98.44M¥ -91.32M¥ -116.21M¥ -82.33M
Investing Cash Flow¥ 0.00¥ -206.24M¥ -95.05M¥ -1.33B¥ -249.18M
Financing Cash Flow¥ 0.00¥ -11.46M¥ -30.26M¥ 2.81B¥ 345.54M
Currency in CNY

Zylox-Tonbridge Medical Technology Co., Ltd. Class H Earnings and Revenue History

Zylox-Tonbridge Medical Technology Co., Ltd. Class H Debt to Assets

Zylox-Tonbridge Medical Technology Co., Ltd. Class H Cash Flow

Zylox-Tonbridge Medical Technology Co., Ltd. Class H Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis